Physician profile
Johnathan Grant
NPI 1740272251
$11,147.53
in general payments reported to CMS, 2019-2025
35 companies · $6,889 in 2025
The $6,889 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $66.29 · 2021: $383 · 2022: $873 · 2023: $1,112 · 2024: $1,361 · 2025: $6,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,153 · Food and Beverage: $3,612 · Travel and Lodging: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,152.98 |
| Food and Beverage | $3,612.31 |
| Travel and Lodging | $1,596.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,613.48 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $993.40 | 2019-2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $911.35 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $564.67 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.39 | 2019-2025 | Jardiance, Ofev, Jascayd |
| Amgen INC. | $361.78 | 2020-2025 | Tezspire, Repatha |
| Mylan Specialty L.P. | $290.57 | 2019-2024 | Yupelri |
| Genzyme Corporation | $246.94 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $212.18 | 2022-2025 | Dupixent |
| United Therapeutics Corporation | $143.22 | 2021-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $138.50 | 2023-2025 | Glassia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.36 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $118.71 | 2019-2025 | Verquvo, Capvaxive |
| Sunovion Pharmaceuticals INC. | $108.46 | 2019 | |
| Grifols USA, LLC | $102.56 | 2019-2025 | Prolastin-C Liquid |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $92.49 | 2023-2025 | |
| Insmed, INC. | $80.62 | 2024-2025 | Arikayce, Brinsupri |
| Verona Pharma, INC. | $67.79 | 2025 | Ohtuvayre |
| Philips North America LLC | $62.10 | 2019-2025 | Coronary Other |
| Novartis Pharmaceuticals Corporation | $55.45 | 2022 | |
| Novo Nordisk INC | $53.61 | 2024-2025 | Wegovy |
| Baxter Healthcare | $41.69 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genentech USA, INC. | $38.00 | 2019 | |
| Viatris Specialty LLC | $37.85 | 2025 | Yupelri |
| Pulmonx Corporation | $32.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.01 | 2023-2024 | Xarelto |
| Electromed, INC. | $29.04 | 2024 | Smartvest |
| Pfizer INC. | $23.56 | 2021 | |
| Abbott Laboratories | $23.23 | 2023 | Cardiomems |
| Resmed Corp | $17.17 | 2022 | |
| Csl Behring | $15.75 | 2025 | Hizentra |
| Amarin Pharma, INC. | $14.38 | 2021 | |
| Inspire Medical Systems, INC. | $13.86 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $13.18 | 2022 | |
| Veran Medical Technologies, INC. | $3.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.